Trials / Sponsors / Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2023-03-03 |
| Terminated | STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia Spinocerebellar Ataxia Type 3 | Phase 2 / Phase 3 | 2022-06-03 |
| Completed | A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Depressive Disorder, Major, Suicidal | Phase 2 | 2020-12-17 |
| No Longer Available | Intermediate-Sized Expanded Access Study Amyotrophic Lateral Sclerosis | — | — |